Giuseppe Curigliano - Dissemin

Language
Login

All papers authored by Giuseppe Curigliano

This paper was not found in any repository, but could be made available legally by the author.

2024 Marisa Cobanaj

ORCID

ORCID

, Edward C. Dee, Lucas McCullum

ORCID

, Laura Boldrini

ORCID

, Ilana Schlam, Sara M. Tolaney, Leo A. Celi, Giuseppe Curigliano

ORCID

, Carmen Criscitiello

ORCID

Advancing equitable and personalized cancer care: Novel applications and priorities of artificial intelligence for fairness and inclusivity in the patient care workflow

Upload

This paper was not found in any repository, but could be made available legally by the author.

2023 Stefania Morganti, Antonio Marra

ORCID

, Sara Gandini, Liliana Ascione

ORCID

, Mariia Ivanova

ORCID

, Konstantinos Venetis

ORCID

, Elham Sajjadi, Paola Zagami

ORCID

, Federica Giugliano

ORCID

, Beatrice Taurelli Salimbeni, Pier Paolo Maria Berton Giachetti, Chiara Corti

ORCID

, Elisa De Camilli, Giuseppe Curigliano

ORCID

ORCID

and 1 other authors

Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study

Upload

This paper was not found in any repository, but could be made available legally by the author.

Konstantinos Venetis, Francesco Pepe, Carlo Pescia, Giulia Cursano, Carmen Criscitiello, Chiara Frascarelli, Eltjona Mane, Gianluca Russo

ORCID

, Beatrice Taurelli Salimbeni, Giancarlo Troncone, Elena Guerini Rocco, Giuseppe Curigliano

ORCID

, Nicola Fusco, Umberto Malapelle

ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing

Upload

This paper is made freely available by the publisher.

Paola Zagami

ORCID

, Dario Trapani

ORCID

, Eleonora Nicolò

ORCID

ORCID

, Carmine Valenza, Carmen Criscitiello, Giuseppe Curigliano

ORCID

, Lisa Anne Carey

ORCID

Cardiotoxicity of Agents Used in Patients With Breast Cancer

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

C. Corti

ORCID

, G. Castellano

ORCID

, G. Curigliano

ORCID

Exploring the utility and limitations of ChatGPT in scientific literature searches

Upload

This paper was not found in any repository, but could be made available legally by the author.

Mariia Ivanova

ORCID

, Francesca Maria Porta

ORCID

, Marianna D’Ercole

ORCID

ORCID

, Elham Sajjadi

ORCID

, Giulia Cursano

ORCID

, Elisa De Camilli

ORCID

ORCID

, Giovanni Mazzarol

ORCID

, Konstantinos Venetis

ORCID

, Elena Guerini-Rocco

ORCID

, Giuseppe Curigliano

ORCID

, Giuseppe Viale

ORCID

ORCID

Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer

Upload

This paper was not found in any repository, but could be made available legally by the author.

Matteo Repetto, Edoardo Crimini

ORCID

ORCID

, Luca Boscolo Bielo, Liliana Ascione

ORCID

, Funda Meric-Bernstam, Alexander Drilon, Giuseppe Curigliano

ORCID

A demand-offer critical analysis of current drug development. Phase I drugs versus TCGA sequencing data

Upload

This paper is made freely available by the publisher.

Mariia Ivanova

ORCID

, Francesca Maria Porta

ORCID

, Federica Giugliano

ORCID

, Chiara Frascarelli, Elham Sajjadi

ORCID

, Konstantinos Venetis, Giulia Cursano, Giovanni Mazzarol, Elena Guerini-Rocco, Giuseppe Curigliano

ORCID

, Carmen Criscitiello, Nicola Fusco

ORCID

Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management

Download from doi.org

This paper is made freely available by the publisher.

Emma Zattarin, Daniele Presti, Luigi Mariani

ORCID

, Caterina Sposetti

ORCID

, Rita Leporati

ORCID

, Alice Menichetti, Chiara Corti

ORCID

, Chiara Benvenuti, Giovanni Fucà

ORCID

, Riccardo Lobefaro, Francesca Ligorio, Leonardo Provenzano, Andrea Vingiani, Marta Del Vecchio, Gaia Griguolo

ORCID

and 24 other authors

Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Matteo Repetto

ORCID

, Edoardo Crimini

ORCID

, Luca Boscolo Bielo

ORCID

, Elena Guerini-Rocco, Liliana Ascione

ORCID

, Andrea Bonfanti, Cristina Zanzottera, Luca Mazzarella, Alberto Ranghiero, Carmen Belli

ORCID

, Carmen Criscitiello

ORCID

, Angela Esposito, Massimo C. P. Barberis, Giuseppe Curigliano

ORCID

Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience

Upload

This paper was not found in any repository, but could be made available legally by the author.

Chiara Corti

ORCID

, Federica Giugliano

ORCID

, Eleonora Nicolò

ORCID

, Paolo Tarantino

ORCID

, Carmen Criscitiello

ORCID

, Giuseppe Curigliano

ORCID

HER2-Low Breast Cancer: a New Subtype?

Upload

This paper is made freely available by the publisher.

Federica Giugliano

ORCID

, Ambra Carnevale Schianca, Chiara Corti

ORCID

, Mariia Ivanova

ORCID

, Nadia Bianco, Silvia Dellapasqua, Carmen Criscitiello

ORCID

ORCID

, Giuseppe Curigliano

ORCID

, Elisabetta Munzone

ORCID

Unlocking the Resistance to Anti-HER2 Treatments in Breast Cancer: The Issue of HER2 Spatial Distribution

Download from doi.org

This paper is made freely available by the publisher.

2022 Liliana Ascione

ORCID

ORCID

, Eleonora Nicolò

ORCID

, Edoardo Crimini, Giuseppe Curigliano

ORCID

, Carmen Criscitiello

ORCID

PIK3CAMutations in Breast Cancer Subtypes Other Than HR-Positive/HER2-Negative

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Gabriele Antonarelli

ORCID

ORCID

, Paolo Andrea Zucali, Matteo Perrino, Sara Manglaviti

ORCID

, Giuseppe Lo Russo, Gianluca Maria Varano

ORCID

, Piermario Salvini, Giuseppe Curigliano

ORCID

, Chiara Catania, Fabio Conforti, Tommaso De Pas

ORCID

Continuous sunitinib schedule in advanced platinum refractory thymic epithelial neoplasms: A retrospective analysis from the ThYmic MalignanciEs (TYME) Italian collaborative group

Upload

This paper was not found in any repository, but could be made available legally by the author.

Chiara Corti

ORCID

, Fabio Conforti, Laura Pala, Chiara Catania, Emilia Cocorocchio, Pier Francesco Ferrucci

ORCID

, Giuseppe Curigliano

ORCID

, Paola Queirolo, Tommaso de Pas

ORCID

Differential activity of avapritinib in patients with metastases from mucosal melanoma and thymic carcinoma harbouring KIT exon 17 mutations: Initial experience from a Compassionate Use Program in Italy

Upload

This paper was not found in any repository, but could be made available legally by the author.

Chiara Corti

ORCID

, Gabriele Antonarelli

ORCID

, Carmine Valenza, Eleonora Nicolò, Hope Rugo, Javier Cortés, Nadia Harbeck, Lisa A. Carey, Carmen Criscitiello, Giuseppe Curigliano

ORCID

Histology-agnostic approvals for antibody–drug conjugates in solid tumours: is the time ripe?

Upload

This paper was not found in any repository, but could be made available legally by the author.

Vivek Subbiah

ORCID

, Philippe A. Cassier, Salvatore Siena

ORCID

, Elena Garralda

ORCID

, Luis Paz-Ares, Pilar Garrido

ORCID

ORCID

, Jacqueline Vuky, Gilberto Lopes, Gregory P. Kalemkerian, Daniel W. Bowles, Mahesh Seetharam, Jianhua Chang, Hui Zhang, Jennifer Green and 4 other authors

Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

Paolo Tarantino

ORCID

, Giuseppe Curigliano

ORCID

, Sara M. Tolaney

ORCID

Navigating the HER2-Low Paradigm in Breast Oncology: New Standards, Future Horizons

Upload

This paper is made freely available by the publisher.

Edoardo Crimini, Matteo Repetto, Paolo Tarantino

ORCID

, Liliana Ascione

ORCID

, Gabriele Antonarelli

ORCID

, Elena Guerini Rocco, Massimo Barberis

ORCID

, Luca Mazzarella, Giuseppe Curigliano

ORCID

Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor Boards

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Federica Giugliano

ORCID

, Paolo A. Zucali

ORCID

, Giulia Galli, Zelmira Ballatore, Chiara Corti

ORCID

, Pamela T. Aliaga

ORCID

, Jacopo Uliano, Grazia Vivanet, Giuseppe Curigliano

ORCID

, Fabio Conforti, Paola Queirolo

ORCID

, Rossana Berardi, Sara Manglaviti, Giulia Apollonio, Matteo Perrino and 4 other authors

SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis

Upload

Missing publications? Search for publications with a matching author name.